Download Files:
Products Details
Product Description
– DW-1350 is a LTB4 receptor antagonist.
Web ID
– HY-100173
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C25H31N3O3S
References
– [1]Kang JH, et al. 5-Lipoxygenase inhibitors suppress RANKL-induced osteoclast formation via NFATc1expression. Bioorg Med Chem. 2015 Nov 1;23(21):7069-78.
CAS Number
– 491577-61-8
Molecular Weight
– 453.60
SMILES
– N=C(C1=CC=C(OCCCCCOC2=CC=C(C3=C(C(C)C)SC(C)=N3)C=C2)C=C1)NO
Clinical Information
– No Development Reported
Research Area
– Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Leukotriene Receptor
Isoform
– LTB4
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation.
